| Literature DB >> 30517006 |
Kang Xiao1, Jie Gao1, Shi-Jia Weng1, Yan Fang1, Na Gao1, Qiang Wen1, Han Jin1, Hai-Ling Qiao1.
Abstract
Testosterone (TST) and midazolam (MDZ) are widely used as probes to detect CYP3A4/5 activity, but the data acquired with these two substrates do not correlate well at the microsomal level (per milligram of microsomal protein), and the reason is unclear. In this study, CYP3A4/5 activity was probed with TST and MDZ at the microsomal and enzyme levels (per picomole of CYP3A4/5) in 72 human liver samples. Correlation coefficients were lower in Vmax and CLint at the microsomal level, as compared with those at the enzyme level ( Vmax 0.658 vs 0.883; CLint no correlation vs 0.796). Compared with TST, MDZ was found to correlate better with the content of CYP3A4/5 (no correlation vs 0.431) and CYP3A5 (no correlation vs 0.447), and huge variations in enzyme content existed among different genotypes, which explained the lower degree of correlation at the microsomal level. In addition, different genotypes had varying effects on activity at the enzyme level, whereas the difference between activity at the enzyme level probed with TST and that probed with MDZ was not obvious ( P > 0.05), indicating that the effect of gene polymorphisms on correlation between activity probed with these two substrates was limited at the enzyme level. In conclusion, our study demonstrates a high degree of correlation between CYP3A4/5 activity probed with TST and MDZ at the enzyme level but not at the microsomal level and allows us to correctly understand the influence of gene polymorphisms on the correlations.Entities:
Keywords: CYP3A4/5 activity; correlation; midazolam; testosterone
Mesh:
Substances:
Year: 2018 PMID: 30517006 DOI: 10.1021/acs.molpharmaceut.8b01043
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939